IVACHTIN,
745046-84-8,
Caspase-3 Inhibitor VII,
2-(4-Methyl-8-(morpholin-4-ylsulfonyl)-1,3-dioxo-1,3-dihydro-2H-pyrrolo[3,4-c]quinolin-2-yl)ethyl acetate,
2-[4-Methyl-8-(morpholin-4-ylsulfonyl)-1,3-dioxo-1,3-dihydro-2H-pyrrolo[3,4-c]quinolin-2-yl]ethyl acetate,
MLS006013365,
CHEMBL192330,
SCHEMBL8312700,
BDBM10358,
CHEBI:93128,
CTK8E7163,
DTXSID80458580,
HMS3269H15,
BCP17017,
ZINC6718487,
AKOS021734943,
MCULE-9535840404,
NCGC00167805-01,
NCGC00167805-02,
SMR004704848,
pyrrolo[3,4-c]-quinoline-1,3-dione 7a,
RT-013388,
FT-0729441,
BRD-K64402243-001-01-1,
2-(4-methyl-8-morpholin-4-ylsulfonyl-1,3-dioxopyrrolo[3,4-c]quinolin-2-yl)ethyl acetate,
2-[4-methyl-8-(morpholinosulfonyl)-1,3-dioxo-1,3-dihydro-2H-pyrrolo[3,4-c]quinolin-2-yl]ethyl acetate,
2-[7-methyl-12-(morpholine-4-sulfonyl)-3,5-dioxo-4,8-diazatricyclo[7.4.0.0^{2,6}]trideca-1(13),2(6),7,9,11-pentaen-4-yl]ethyl acetate,
4-[[2-[2-(Acetyloxy)ethyl]-2,3-dihydro-4-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]quinolin-8-yl]sulfonyl]-morpholine,
Acetic acid 2-[4-methyl-8-(morpholine-4-sulfonyl)-1,3-dioxo-1,3-dihydro-pyrrolo[3,4-c]quinolin-2-yl]-ethyl ester,
PHTPP,
CID11201705,
CID 11201705,
A4417,
A15300,
805239-56-9,